94 related articles for article (PubMed ID: 27486019)
1. Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.
Koboldt DC; Kanchi KL; Gui B; Larson DE; Fulton RS; Isaacs WB; Kraja A; Borecki IB; Jia L; Wilson RK; Mardis ER; Kibel AS
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1456-1463. PubMed ID: 27486019
[TBL] [Abstract][Full Text] [Related]
2. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry.
Soh PXY; Mmekwa N; Petersen DC; Gheybi K; van Zyl S; Jiang J; Patrick SM; Campbell R; Jaratlerdseri W; Mutambirwa SBA; Bornman MSR; Hayes VM
Nat Commun; 2023 Dec; 14(1):8037. PubMed ID: 38052806
[TBL] [Abstract][Full Text] [Related]
4. Distinctive DNA mismatch repair and APC rare variants in African Americans with colorectal neoplasia.
Ashktorab H; Azimi H; Varma S; Tavakoli P; Nickerson ML; Brim H
Oncotarget; 2017 Nov; 8(59):99966-99977. PubMed ID: 29245953
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: Aggressive variant prostate cancer: An exemplary case study and comprehensive literature survey.
Ke HW; Zhang WY; Xu KX
World J Clin Cases; 2023 Dec; 11(35):8431-8433. PubMed ID: 38130605
[TBL] [Abstract][Full Text] [Related]
6. Recruiting African American Prostate Cancer Survivors for a Population-based Biobank Study.
Li X; Roy S; Damonte J; Park HY; Hoogland AI; Jamison K; Komrokji KR; Yeo CD; Kim Y; Dhillon J; Gudenkauf LM; Oswald LB; Jim HSL; Yamoah K; Pow-Sang JM; Kanetsky PA; Gwede CK; Park JY; Gonzalez BD
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):768-775. PubMed ID: 36958853
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.
Wang A; Xu Y; Yu Y; Nead KT; Kim T; Xu K; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Stopsack KH; Mucci LA; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; de Smith AJ; Conti DV; Huff C; Haiman CA; Darst BF
Hum Mol Genet; 2023 Jan; 32(3):489-495. PubMed ID: 36018819
[TBL] [Abstract][Full Text] [Related]
8. Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers.
Guo N; Chen Y; Jing Z; Liu S; Su J; Li R; Duan X; Chen Z; Chen P; Yin R; Li S; Tang J
Front Bioeng Biotechnol; 2022; 10():909388. PubMed ID: 35923575
[TBL] [Abstract][Full Text] [Related]
9. Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations.
Guan Z; Shen R; Begg CB
Hum Hered; 2021; 86(1-4):34-44. PubMed ID: 34718237
[TBL] [Abstract][Full Text] [Related]
10. TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract][Full Text] [Related]
11. Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.
Saunders EJ; Kote-Jarai Z; Eeles RA
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673083
[TBL] [Abstract][Full Text] [Related]
12. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.
Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA
J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339
[TBL] [Abstract][Full Text] [Related]
13. Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
Lee MJ; Koff JL; Switchenko JM; Jhaney CI; Harkins RA; Patel SP; Dave SS; Flowers CR
Cancer; 2020 Aug; 126(15):3493-3503. PubMed ID: 32469082
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.
Rotunno M; Barajas R; Clyne M; Hoover E; Simonds NI; Lam TK; Mechanic LE; Goldstein AM; Gillanders EM
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1519-1534. PubMed ID: 32467344
[TBL] [Abstract][Full Text] [Related]
15. Ten-eleven translocation-2 affects the fate of cells and has therapeutic potential in digestive tumors.
Wang F; Zhang J; Qi J
Chronic Dis Transl Med; 2019 Dec; 5(4):267-272. PubMed ID: 32055786
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
[TBL] [Abstract][Full Text] [Related]
17. Stepwise approach to SNP-set analysis illustrated with the Metabochip and colorectal cancer in Japanese Americans of the Multiethnic Cohort.
Cologne J; Loo L; Shvetsov YB; Misumi M; Lin P; Haiman CA; Wilkens LR; Le Marchand L
BMC Genomics; 2018 Jul; 19(1):524. PubMed ID: 29986644
[TBL] [Abstract][Full Text] [Related]
18. Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Mijuskovic M; Saunders EJ; Leongamornlert DA; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Govindasami K; Brook MN; Haiman CA; Conti DV; Eeles RA; Kote-Jarai Z
Br J Cancer; 2018 Jul; 119(1):96-104. PubMed ID: 29915322
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
Tan SH; Petrovics G; Srivastava S
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
[TBL] [Abstract][Full Text] [Related]
20. Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression.
Takayama KI; Misawa A; Inoue S
Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28783103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
